Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02737501 |
|---|---|
| Brief Title: | ALTA-1L Study: A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) Participants (ALTA-1L) |
| First Submitted : | March 30, 2016 |
| First Submitted that Met QC Criteria : | April 11, 2016 |
| First Posted : | April 14, 2016 (Estimate) |
| Results First Submitted : | July 27, 2021 |
| Results First Submitted that Met QC Criteria : | July 27, 2021 |
| Results First Posted : | August 20, 2021 |
| Last Update Submitted that Met QC Criteria : | July 27, 2021 |
| Last Update Posted : | August 20, 2021 |